orphan drug

(redirected from Orphan drugs)
Also found in: Medical, Encyclopedia.
Related to Orphan drugs: orphan disease

or′phan drug′


n.
a drug that remains undeveloped or is neglected because of limited potential for commercial gain.
[1975–80]
References in periodicals archive ?
The analysis examines the basis for the agency's approval of 135 noncancer "orphan drugs" (those for rare diseases) since the Orphan Drug Act was enacted in 1983 to provide incentives to encourage development of treatments for rare diseases.
In 1983, Congress passed the Orphan Drug Act to encourage development of pharmaceuticals used in the treatment or diagnosis of diseases that occur so rarely that there is no financial incentive for development of these so-called "orphan drugs." The Act established, among other things, exclusive marketing rights on unpatentable orphan drugs for a period of seven years and a tax credit equal to 50 percent of the cost of conducting human clinical trials.
So-called orphan drugs often encounter high hurdles during the research and development process.
A survey that was recently conducted by the trade organization shows that 64 orphan drugs have been approved by the Food and Drug Administration for treating 74 conditions and that 189 such medications are in development.
WASHINGTON--According to a survey by the Pharmaceutical Manufacturers Association, Orphan Drugs in Development, 189 treatments for rare diseases are currently in human clinical trials or are being reviewed by the Food and Drug Administration.
WASHINGTON--Two orphan drugs made by Genentech Inc.
Survey says orphan drugs are getting strong backing
M2 PRESSWIRE-July 29, 2019-: Orphan Drugs Market is expected to reach $169 billion from $106 billion and register a CAGR of 6.8% by 2022
The announcement sounded special to the investors of the mid-cap firm from Vadodara, in the western Indian state of Gujarat, because the news came at a time when the industry is riding a wave of orphan drugs. Drugs for uncommon conditions that usually affect a small number of patients have been historically neglected by drug majors.
[USPRwire, Tue Mar 12 2019] Market Research Reports Search Engine (MRRSE) has recently updated its massive report catalogue by adding a fresh study titled " Orphan Drugs Market Projections & Future Opportunities Recorded for the Period until 2025".
For the treatment of these rare diseases pharmaceutical agents are specifically developed which are known as orphan drugs.
Large, multinational pharmaceutical firms are continuing to push up prices for orphan drugs (OD), despite healthcare bodies and patients across Europe calling for more affordable treatment plans, it emerged on Tuesday.